Key facts
as of Sep 2026- InformAI’s last known valuation is $17.0M (Apr 2021).
- It has raised $3.6M; the latest was Later Stage VC in Jun 2025.
- Notable investors include US National Science Foundation, National Institutes of Health, Texas Medical Center, Joyance Partners, Cancer Prevention and Research Institute of Texas — 7 tracked in total.
- 1 institutional filer reports fund marks on InformAI across 10 filings.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for InformAI
- ·The full record, as it builds
Recorded secondary trades
No secondary trades in InformAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
1 filers · latest Apr 20261 SEC-registered fund reported 10 fair-value marks on InformAI between Apr 2025 and Apr 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No funding rounds for InformAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InformAI
Developer of medical data analytics software designed to improve patient outcomes and operational functions and enable large dataset synthesis in clinical care. The company's software provides artificial intelligence and deep learning algorithms for magnetic resonance imaging, computed tomography scan image classification, natural language processing of medical reports for business analytics, and predictive tools for healthcare business and patient management and to solve clinical pain points identified by key opinion leaders, enabling healthcare organizations and medical research institutes to assist in improving patient outcomes and operational efficiency.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2017
- Employees
- 11
- Website
- informai.com/
- Ownership
- Privately Held (backing)